Session Information

Submitted Course

[SC-TH-69] Bevacizumab (Avastin) Use for Typical Stage 3+ or Aggressive Posterior Retinopathy of Prematurity: Anti-VEGF Mechanism; Treatment and Follow-Up; Regression and Recurrence; Short and Long Term Ocular and Systemic Outcomes
Go back
print
Day
Apr 03 (Thu)
Time
15:30 - 17:00
Room
Room 15 - Tokyo International Forum 4F G407
Topic
Retina - Medical

Go back